Moleculin Biotech (MBRX) Stock Rockets On Rare Pediatric Disease Designation
Moleculin Biotech Inc (NASDAQ: MBRX) is screaming for the top in the market this morning, and for good reason. The company announced that the FDA… Read More »Moleculin Biotech (MBRX) Stock Rockets On Rare Pediatric Disease Designation